Related references
Note: Only part of the references are listed.MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation
Yuanzhang Fang et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
Wan-li Zhang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
Shelly Kalaora et al.
NATURE COMMUNICATIONS (2020)
ST2 as checkpoint target for colorectal cancer immunotherapy
Kevin Van der Jeught et al.
JCI INSIGHT (2020)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Defining and Understanding Adaptive Resistance in Cancer Immunotherapy
Tae Kon Kim et al.
TRENDS IN IMMUNOLOGY (2018)
Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
Mirjana Efremova et al.
NATURE COMMUNICATIONS (2018)
Repression of PDK1-and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells
Qian Xiao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells
Yukiyoshi Mita et al.
INTERNATIONAL IMMUNOLOGY (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Impact of oncogenic pathways on evasion of antitumour immune responses
Stefani Spranger et al.
NATURE REVIEWS CANCER (2018)
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman et al.
NATURE COMMUNICATIONS (2017)
Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson's Disease
Sandeep More et al.
NUTRIENTS (2017)
Immunoproteasome functions explained by divergence in cleavage specificity and regulation
Michael B. Winter et al.
ELIFE (2017)
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
Marco Donia et al.
CANCER RESEARCH (2017)
Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor
Kenji Fujiyoshi et al.
ANTICANCER RESEARCH (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
Marie de Charette et al.
EUROPEAN JOURNAL OF CANCER (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Targeting the tumor microenvironment to enhance antitumor immune responses
Kevin Van der Jeught et al.
Oncotarget (2015)
The immunoproteasome and viral infection: a complex regulator of inflammation
Mary K. McCarthy et al.
FRONTIERS IN MICROBIOLOGY (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
DNA damage emergency: cellular garbage disposal to the rescue?
H. R. Stone et al.
ONCOGENE (2014)
MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
Patrizia Leone et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
El-ad David Amir et al.
NATURE BIOTECHNOLOGY (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
The MHC I loading complex: a multitasking machinery in adaptive immunity
Sabine Hulpke et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Immune and non-immune functions of the immunoproteasome
Arkhjamil Angeles et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Complete subunit architecture of the proteasome regulatory particle
Gabriel C. Lander et al.
NATURE (2012)
Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach
Keren Lasker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The role of classical and non-classical HLA class I antigens in human tumors
Juergen Bukur et al.
SEMINARS IN CANCER BIOLOGY (2012)
Potential reproductive toxicity of Largehead Atractylodes Rhizome, the most commonly used Chinese medicine for threatened miscarriage
L. Li et al.
HUMAN REPRODUCTION (2011)
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
Isabel Maleno et al.
IMMUNOGENETICS (2011)
Chemoselective enrichment for natural products discovery
Antoinette Y. Odendaal et al.
CHEMICAL SCIENCE (2011)
Quantitative Proteomics Analysis of Cell Cycle-regulated Golgi Disassembly and Reassembly
Xuequn Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Structure of Rpn10 and Its Interactions with Polyubiquitin Chains and the Proteasome Subunit Rpn12
Christiane Riedinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Early endosomes and endosomal coatomer are required for autophagy
Minoo Razi et al.
JOURNAL OF CELL BIOLOGY (2009)
Depletion of beta-COP reveals a role for COP-I in compartmentalization of secretory compartments and in biosynthetic transport of caveolin-1
Melanie L. Styers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Pro-oxidant and cytotoxic activities of atractylenolide I in human promyeloleukemic HL-60 cells
Ching-Chiung Wang et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
